세계의 진단용 인공지능 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2030년)

The global demand for Artificial Intelligence in Diagnostics Market is presumed to reach the market size of nearly USD 3305.22 MN by 2030 from USD 610.1 MN in 2022 with a CAGR of 27.3% under the study period 2023 - 2030.

Artificial intelligence (AI) in diagnostics is utilized to analyse complex medical and imaging data and approximate human cognition. For instance, AI could support healthcare procedures by checking patients' vital signs, answering their questions, and providing them with medications. During medical procedures, AI systems can also be utilised for alerts and reminders, picture interpretation, information retrieval, and therapeutic planning. Multiple technologies, including machine learning, vision, reasoning, and natural language processing, are combined to create artificial intelligence.

MARKET DYNAMICS:

A major factor boosting the growth of artificial intelligence in the diagnostics market is the growing demand to improve patient care and lower treatment costs. Compared to a traditional evaluation of images produced by X-beams and MRIs, artificial intelligence in clinical imaging leads to speedier decisions and fewer errors. Some key obstacles that could limit the growth of artificial intelligence (AI) in the diagnostics market include medical ethics concerns, liability for medical errors, and system failure risks. The problem of data sharing by multiple organisational silos is another important consideration. Regardless, AI and deep learning improvements are anticipated to make disease diagnosis more accurate over the following few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of artificial intelligence in diagnostics. The growth and trends of artificial intelligence in diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the artificial intelligence in diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Component

• Software
• Hardware
• Services

By Diagnosis Type

• Cardiology
• Oncology
• Pathology
• Radiology
• Chest And Lung
• Neurology
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Artificial Intelligence in Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the artificial intelligence in diagnostics market include Siemens Healthineers, Zebra Medical Vision Inc., Riverain Technologies, Vuno, Inc., Aidoc, Neural Analytics, Imagen Technologies, Digital Diagnostics Inc., GE Healthcare, AliveCor Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Component
  • 3.7.2 Market Attractiveness Analysis By Diagnosis Type
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET ANALYSIS BY COMPONENT

• 6.1 Overview by Component
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Component
• 6.4 Software Historic and Forecast Sales by Regions
• 6.5 Hardware Historic and Forecast Sales by Regions
• 6.6 Services Historic and Forecast Sales by Regions

7 . GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET ANALYSIS BY DIAGNOSIS TYPE

• 7.1 Overview by Diagnosis Type
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Diagnosis Type
• 7.4 Cardiology Historic and Forecast Sales by Regions
• 7.5 Oncology Historic and Forecast Sales by Regions
• 7.6 Pathology Historic and Forecast Sales by Regions
• 7.7 Radiology Historic and Forecast Sales by Regions
• 7.8 Chest And Lung Historic and Forecast Sales by Regions
• 7.9 Neurology Historic and Forecast Sales by Regions
• 7.10. Others Historic and Forecast Sales by Regions

8 . GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS COMPANIES

• 9.1. Artificial Intelligence In Diagnostics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Siemens Healthineers
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Zebra Medical Vision Inc.
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Riverain Technologies
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Vuno Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Aidoc
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Neural Analytics
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Imagen Technologies
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Digital Diagnostics Inc.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. GE Healthcare
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. AliveCor Inc.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies